Six Versus Three Doses of Intrapleural Streptokinase in Childhood Empyema: A Randomized Controlled Trial

In children with empyema, intrapleural therapy with six doses of SK is not superior to three doses, although it is safe.

Authors

Institutions

Publication Details

Journal
Pediatric Pulmonology
Published
2024-12-31
DOI
https://doi.org/10.1002/ppul.27465
Citations
5
Primary Topic
Pleural and Pulmonary Diseases
Type
article
Field-Weighted Citation Impact
2.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Six Versus Three Doses of Intrapleural Streptokinase in Childhood Empyema: A Randomized Controlled Trial

Chirag Thakur, Akshay Kumar Saxena, Joseph L. Mathew, Archana Angrup et al.
5 citations
Pediatric Pulmonology
Pleural and Pulmonary Diseases
2.09
article

Six Versus Three Doses of Intrapleural Streptokinase in Childhood Empyema: A Randomized Controlled Trial

Chirag Thakur, Akshay Kumar Saxena, Joseph L. Mathew, Archana Angrup, Ram Samujh
article en
5 citations

Abstract

In children with empyema, intrapleural therapy with six doses of SK is not superior to three doses, although it is safe.

Pediatric PulmonologyVol. 60(1)
Post Graduate Institute of Medical Education and Research (IN)
Good health and well-being
Openalex Percentile: Top 11%
Pleural and Pulmonary Diseases
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Six Versus Three Doses of Intrapleural Streptokinase in Childhood Empyema: A Randomized Controlled Trial — Chirag Thakur, Akshay Kumar Saxena, et al. · Pediatric Pulmonology (2024) | TGRS Research Map | TGRS